Company: SHPH
Filing Date: 2025-03-31
Form Type: DEF 14A
Source: 0001641172-25-001889
Chunk: 43

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-31
Form: DEF 14A
Chunk 43
---
 stock by a ratio in the range of 1-for-3 to 1-for-10. |
| ● | Proposal 5: Approval of the first amendment to the Shuttle                                                                        
 Pharmaceuticals Holdings, Inc.’s 2018 Equity Incentive Plan to increase the amount of shares reserved for issuance by 5,000,000   
 shares of common stock.                                                                                                           |

What is the effect of giving a proxy?

Whichever method you use to transmit your voting instructions, your shares of Shuttle Pharmaceuticals common Stock will be voted as you direct. If you designate the proxy named on the proxy card to vote on your behalf, but do not specify how to vote your shares, they will be voted as follows:

| ● 
 ● | Proposal                                                                                                                          
 1: FOR ALL NOMINEES for the election of directors.                                                                                
 Proposal                                                                                                                          
 2: FOR the ratification of the appointment of Forvis Mazars, LLP as the Company’s independent auditor for the fiscal              
 year ending December 31, 2025.                                                                                                    |
|:--|:----------------------------------------------------------------------------------------------------------------------------------|
| ● | Proposal                                                                                                                          
 3: FOR the approval (on an advisory basis) of the Company’s executive compensation.                                               |
| ● | Proposal                                                                                                                          
 4: FOR the authorization of the Board of Directors to amend the Company’s amended and restated certificate of incorporation       
 to effect a Reverse Stock Split of all of the Company’s issued and outstanding common stock by a ratio in the range of 1-for-3    
 to 1-for-10.                                                                                                                      |
| ● | Proposal 5: FOR the approval of the first amendment to                                                                            
 the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan to increase the number of shares reserved for issuance by   
 5,000,000 shares of common stock.                                                                                                 |
| ● | FOR                                                                                                                               
 any other matters that may arise at the Annual Meeting, such matters will be voted in accordance with the judgment of the persons 
 voting the proxy on any other matter properly brought before the meeting.                                                         |

If you vote in advance using one of the methods described above, then you may still attend and vote at the Annual Meeting. Please see Revoking a Proxy below for additional details.

If you vote your proxy, your vote must be received by 11:59 P.M. U.S. EST on May 8, 2025 in order for your vote to be counted.

What are the effects of abstentions and broker non-v